The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK

被引:266
作者
Le Jeune, Ivan
Gribbin, Jonathan
West, Joe
Smith, Chris
Cullinan, Paul
Hubbard, Richard
机构
[1] City Hosp Nottingham, Nottingham NG5 1PB, England
[2] Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England
[3] Queens Med Ctr, Nottingham NG7 2UH, England
关键词
neoplasms; epidemiology; sarcoidosis; pulmonary fibrosis;
D O I
10.1016/j.rmed.2007.07.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this study was to use a longitudinal computerised health care dataset (The Health Improvement Network) to provide information on the overall incidence of cancer, and on the incidence of organ-specific cancers, in people with idiopathic pulmonary fibrosis (IPF) and sarcoidosis in comparison to the general population. Methods: Incident cases of IPF and sarcoidosis were identified with up to four controls matched by age, gender and general practice. Cancer incidence rates were compared between cohorts using Cox regression and adjusting for age, gender and smoking habit. Results: One thousand and sixty-four incident cases of IPF (mean age at diagnosis 71.5 years; 62.4% male) were identified. Overall, the incidence of cancer was increased in people with IPF compared to the general population (rate ratio 1.51; 95% Cl 1.20-1.90), but this was largely due to a marked increase in the incidence of lung cancer (rate ratio 4.96; 95% Cl 3.00-8.18). One thousand one hundred and fifty-three incident cases of sarcoidosis (mean age at diagnosis 47.0 years; 47.2% male) were identified. There was an overall increased incidence of cancer in sarcoidosis (rate ratio 1.65; 95% Cl 1.22-2.24) and this was largely explained by an increase in the incidence of skin cancers (rate ratio 1.86; 95% Cl 1.11-3.11). Conclusions: This study provides further evidence of a marked increase in the incidence of lung cancer in people with IPF, but we found no increase in the risk of other cancers. People with sarcoidosis did have an increase risk of skin cancers, but not cancers at other sites. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2534 / 2540
页数:7
相关论文
共 19 条
[1]   Increased risk for cancer following sarcoidosis [J].
Askling, J ;
Grunewald, J ;
Eklund, A ;
Hillerdal, G ;
Ekbom, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) :1668-1672
[2]   Clinical characteristics of patients in a case control study of sarcoidosis [J].
Baughman, RP ;
Teirstein, AS ;
Judson, MA ;
Rossman, MD ;
Yeager, H ;
Bresnitz, EA ;
DePalo, L ;
Hunninghake, G ;
Iannuzzi, MC ;
Johns, CJ ;
McLennan, G ;
Moller, DR ;
Newman, LS ;
Rabin, DL ;
Rose, C ;
Rybicki, B ;
Weinberger, SE ;
Terrin, ML ;
Knatterud, GL ;
Cherniak, R .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) :1885-1889
[3]   Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis [J].
Baumgartner, KB ;
Samet, JM ;
Stidley, CA ;
Colby, TV ;
Waldron, JA ;
Coultas, DB ;
Davis, GS ;
Garcia, JGN ;
Hunninghake, GW ;
Kallay, MC ;
King, TE ;
Krowka, MJ ;
Rennard, SI ;
Ryu, JH ;
Sherman, CB ;
Smith, LJ ;
Toews, G ;
Winterbauer, RH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) :242-248
[4]  
Bourke Alison, 2004, Inform Prim Care, V12, P171
[5]   SOLID TUMORS PRECEDING OR FOLLOWING SARCOIDOSIS [J].
BRINCKER, H .
MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (02) :82-88
[6]   INCIDENCE OF MALIGNANT-TUMORS IN PATIENTS WITH RESPIRATORY SARCOIDOSIS [J].
BRINCKER, H ;
WILBEK, E .
BRITISH JOURNAL OF CANCER, 1974, 29 (03) :247-251
[7]  
Brincker H, 1989, Sarcoidosis, V6, P31
[8]  
*GEN PRACT RES DAT, 1996, OFF NAT STAT
[9]   Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer? [J].
Harris, JM ;
Cullinan, P ;
McDonald, J .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1998, 52 (09) :602-603
[10]   Lung cancer and cryptogenic fibrosing alveolitis - A population-based cohort study [J].
Hubbard, R ;
Venn, A ;
Lewis, S ;
Britton, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (01) :5-8